Advertisement

Related Videos

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Welcome and Introduction to Vi3C

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Advertisement

Advertisement




Jan
27
Today In Oncology
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Cabozantinib and Temozolomide in Unresectable or Metastatic Leiomyosarcoma
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo